Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
NCR Voyix
VYX
$1.13B
| $3.08M | ﹤0.01% |
289,416
+200,178
| +224% | +$2.29M |
|
3652
CALL
Altimmune
ALT
$572M
| $3.07M | ﹤0.01% |
286,900
+230,900
| +412% | +$1.27M |
|
|
INFO
3653
PUT
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $3.07M | ﹤0.01% |
40,700
+30,800
| +311% | +$2.1M |
|
3654
CALL
Everest Group
EG
$14.2B
| $3.07M | ﹤0.01% |
14,900
+3,800
| +34% | +$740K |
|
3655
ArcBest
ARCB
$3.19B
| $3.07M | ﹤0.01% |
115,865
-27,302
| -19% | -$585K |
|
3656
WisdomTree US Value Fund
WTV
$3.4B
| $3.07M | ﹤0.01% |
77,970
+36,438
| +88% | +$1.36M |
|
3657
WisdomTree International AI Enhanced Value Fund
AIVI
$63.5M
| $3.07M | ﹤0.01% |
86,361
+62,098
| +256% | +$2.11M |
|
3658
CALL
Federal Realty Investment Trust
FRT
$10.3B
| $3.07M | ﹤0.01% |
36,000
+20,600
| +134% | +$1.66M |
|
3659
PUT
Public Service Enterprise Group
PEG
$37.9B
| $3.07M | ﹤0.01% |
62,400
+56,000
| +875% | +$2.79M |
|
3660
Vornado Realty Trust
VNO
$7.28B
| $3.07M | ﹤0.01% |
+80,291
| New | +$3.12M |
|
3661
WisdomTree US Total Dividend Fund
DTD
$1.7B
| $3.07M | ﹤0.01% |
68,054
-53,482
| -44% | -$2.33M |
|
3662
Inogen
INGN
$153M
| $3.07M | ﹤0.01% |
86,335
+44,243
| +105% | +$1.86M |
|
3663
CALL
Stellantis
STLA
$20.2B
| $3.07M | ﹤0.01% |
299,400
-685,600
| -70% | -$5.93M |
|
3664
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $3.06M | ﹤0.01% |
56,955
-711,826
| -93% | -$37.8M |
|
3665
PUT
Vanguard High Dividend Yield ETF
VYM
$84B
| $3.06M | ﹤0.01% |
38,900
+21,700
| +126% | +$1.69M |
|
3666
PUT
Tenet Healthcare
THC
$21.6B
| $3.06M | ﹤0.01% |
169,200
+78,300
| +86% | +$1.54M |
|
3667
CALL
Bank of Montreal
BMO
$130B
| $3.06M | ﹤0.01% |
57,700
+10,600
| +23% | +$540K |
|
3668
CALL
Hyatt Hotels
H
$17.1B
| $3.06M | ﹤0.01% |
60,800
+2,900
| +5% | +$154K |
|
|
FRTA
3669
DELISTED
Forterra, Inc
FRTA
| $3.06M | ﹤0.01% |
274,028
+116,933
| +74% | +$965K |
|
3670
CALL
Editas Medicine
EDIT
$433M
| $3.05M | ﹤0.01% |
103,200
+53,400
| +107% | +$1.4M |
|
3671
PUT
Dillards
DDS
$8.76B
| $3.05M | ﹤0.01% |
118,300
+4,000
| +3% | +$113K |
|
3672
PUT
ACM Research
ACMR
$5.6B
| $3.05M | ﹤0.01% |
146,700
+87,300
| +147% | +$1.43M |
|
|
CLLS
3673
Cellectis
CLLS
$307M
| $3.05M | ﹤0.01% |
171,279
-84,749
| -33% | -$1.29M |
|
3674
Martin Marietta Materials
MLM
$32.9B
| $3.04M | ﹤0.01% |
14,738
-103,460
| -88% | -$19.9M |
|
|
MIC
3675
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $3.04M | ﹤0.01% |
99,200
-11,900
| -11% | -$329K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.